Skip to content
Disclosery

EXANE DERIVATIVES: SJM position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on SJM, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 13 SJM shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 13 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $1,664.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 13 shares
    Change vs previous 13F -3,449 shares

    <0.01% of the 13F portfolio, value $1,760.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 3,462 shares
    Change vs previous 13F +2,846 shares

    0.11% of the 13F portfolio, value $470,192.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 616 shares
    Change vs previous 13F -3,242 shares

    0.02% of the 13F portfolio, value $73,936.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 3,858 shares
    Change vs previous 13F -3,742 shares

    0.12% of the 13F portfolio, value $500,525.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 7,600 shares
    Change vs previous 13F +2,928 shares

    0.29% of the 13F portfolio, value $961,585.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 4,672 shares
    Change vs previous 13F -8,408 shares

    0.16% of the 13F portfolio, value $540,058.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 13,080 shares
    Change vs previous 13F not available

    0.49% of the 13F portfolio, value $1,510,918.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).